In the United States, prescription drug abuse is on the rise. This trend has impacted the makers of OxyContin®, as well as the manufacturers of other controlled substances,to reevaluate how they formulate their products, resulting in medications, that are more difficult to abuse. These abuse-deterrent formulations utilize physical, chemical and aversion barriers, specific delivery systems, and prodrug technology to prevent abuse. Additionally, some manufacturers have implemented the use of risk-management campaigns and education programs, to reduce the misuse of their products. Working together with prescription drug manufacturers, pharmacists play an important role in preventing abuse and educating patients on the appropriate use of their prescriptions.
Hoersten AR, Hedrick N, Shumate L, Stewart HP, Swann C, Milks M. Prescription Drug Manufacturer Attempts to Prevent Abuse of Controlled Substances. PAW Review. 2011 May 01; 2(2):Article 14 11-13 . Available from: https://digitalcommons.onu.edu/paw_review/vol2/iss2/14.